Abstract

Guidelines for the Submission

The deadline for online-only submission of Abstracts is strictly 15 November, 2024.
Abstracts are to be submitted through the internet website https://30ssog.com/ or regular e-mail: abstract@30ssog.com, following strictly the specific guidelines.
Confirmation of acceptance by the Scientific Committee will be sent by email on 10th January 2025.
In order to avoid disruption of the session by “no-shows,” accepted Abstracts will only be integrated into the Final Program if the confirmation of acceptance has been received by January 20, 2024!
The length of the abstract text is limited to 250-350 words (double space, Times New Roman, font size 14).
Text shall be structured as follows:
- Introduction
- Materials & Methods
- Results
One table and one picture only may be included.
After acceptance, the exchange of the Presenting Author will only be possible with the approval of the written request by the Scientific Committee by January 20, 2024.
The Presenting Author’s Name must be identical to what will be written in the Congress Registration Form.
Mailing Address – Any communication regarding the acceptance will only be given to the Submitting Author at the address or email address as registered.
Each Presenting Author of an accepted abstract must submit a Disclosure Form showing commercial, financial, or research relationships or interests.
The Oral Presentation must be presented by a consultant or specialist.

NOTE:
In case you encounter any difficulties with the submission of your Abstract, please contact the Abstract Secretariat at Phone: 0000-000-0000.

Author Name

Author's Email Address

Author's Telephone

Author's Country

Is this your first submission to the research in a conference?

Position in research

Presentation Title

Type of Presentation

Oral Presentation Poster Presentation (Electronic)

Presenting Author

Presenting Author's Academic Degree

Presenting Author's Email Address

Presenting Author's Academic/Hospital Affiliations

Presenting Author's Complete Mailing Address

Presenting Author's Telephone Number

Co-Authors Names

Is this abstract published?

If published please provide publication link, journal name and research category

Select appropriate general topic category for your submission

Abstract Information - Introduction

Aims

Methods

Results

Discussion

Conclusion

References

What professional practice gap does this abstract address?

How will this abstract influence change in competence, performance or patient outcomes?

Off-Label Use

This presentation DOES NOT include information about product(s) not labeled for use or investigational This presentation DOES include information about product(s) not labeled for use or investigational. (See next box for specific information). I understand that I must disclose this information to the audience prior to the presentation

Off-Label Procedure(s)/Product(s) under investigation are: (please be specific)

Conflict of Interest

I DO NOT have a Conflict of Interest A Conflict of Interest DOES EXIST. I understand that it is necessary that the conflict of interest be identified openly at the beginning of my presentation so that the audience may form their own judgments about the presentation with the full disclosure of the fact of my presentation. (My conflict is listed below).

Nature of Conflict (be specific)

Upload a file to be included with the above submission

I accept that the content of this abstract cannot be modified or corrected after final submission and I am aware that it will be published exactly as submitted. Submission of the abstract constitutes my consent to publication (e.g. conference website, programs, other promotions, etc.) The Abstract Submitter warrants and represents that he/she is the sole owner or has the rights of all the information and content provided to PRRAS2024 scientific committee and GDEDA (GDEDA: “The Organizers”). Submissions should follow appropriate ethical guidelines. The publication of the abstract does not infringe any third party rights including, but not limited to, intellectual property rights. As the organizers will work to publish and advertise the accepted abstracts , the Abstract Submitter grants the Organizers a royalty-free, perpetual, irrevocable nonexclusive license to use, publish, translate, distribute, and display the Content. The Organizers reserve the right to remove from any publication an abstract which does not comply with the above. The corresponding author is responsible for informing the other authors about the status of the abstract

Abstract

Guidelines for the Submission

© 2024 30SSOQ. All rights reserved